Related Experiment Video
Updated: Apr 20, 2026

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration
Published on: May 19, 2016
FERM domain-containing protein FRMD5 regulates cell motility via binding to integrin β5 subunit and ROCK1
Jinxia Hu1, Miaomiao Niu2, Xueying Li2
1Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University Health Science Center, Beijing 100191, China; State Key Laboratory of Natural and Biomimetic Drugs, Peking University Health Science Center, Beijing 100191, China; Laboratory of Molecular Cell Biology and Tumor Biology, Department of Anatomy, Histology and Embryology, Peking University Health Science Center, Beijing 100191, China; Department of Biochemistry and Molecular Biology, Peking University Health Science Center, Beijing 100191, China; Department of Biochemistry and Molecular Biology, Binzhou Medical University, Yantai 264000, Shandong, China.
Abstract:
FRMD5 is a novel FERM domain-containing protein depicted in tumor progression. However, the mechanisms underlying FRMD5 inhibition of cell migration is largely unknown. Here, we show that FRMD5 regulates cell migration by interacting with integrin β5 cytoplasmic tail and ROCK1 in human lung cancer cells. FRMD5 promotes cell-matrix adhesion and cell spreading on vitronectin, and thus inhibits cell migration. Furthermore, FRMD5 interacts with ROCK1 and inhibits its activation that leads to the inhibition of myosin light chain phosphorylation and the actin stress fiber formation. Taken together, these findings demonstrate that the putative tumor suppressive protein FRMD5 regulates tumor cell motility via a dual pathway involving FRMD5 binding to integrin β5 tail and to ROCK1.
Insights
FRMD5 protein inhibits lung cancer cell migration by promoting adhesion and inhibiting ROCK1 activation. This dual mechanism involves binding to integrin β5 and ROCK1, revealing FRMD5
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- FRMD5 (FERM domain-containing protein 5) is implicated in tumor progression.
- The precise mechanisms by which FRMD5 inhibits cancer cell migration remain unclear.
Purpose of the Study:
- To elucidate the molecular mechanisms of FRMD5-mediated inhibition of cell migration in human lung cancer.
- To investigate the interactions of FRMD5 with key cellular components involved in cell motility.
Main Methods:
- Investigated FRMD5 interactions with integrin β5 cytoplasmic tail and ROCK1 in lung cancer cells.
- Assessed the effects of FRMD5 on cell-matrix adhesion, cell spreading, and cell migration.
- Analyzed ROCK1 activation, myosin light chain phosphorylation, and actin stress fiber formation.
Main Results:
- FRMD5 interacts with integrin β5 and ROCK1, inhibiting lung cancer cell migration.
- FRMD5 enhances cell-matrix adhesion and cell spreading on vitronectin.
- FRMD5 binding to ROCK1 suppresses its activation, leading to reduced myosin light chain phosphorylation and actin stress fiber formation.
Conclusions:
- FRMD5 acts as a tumor suppressor by inhibiting cell motility through a dual pathway.
- FRMD5 regulates tumor cell migration via interactions with integrin β5 and ROCK1.
More Related Videos
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
Cytoskeletal Coordination in Cell Migration
Cell Motility through Blebbing
Blebbing Through the Matrix
In multicellular...
Cell Polarization by Rho Proteins

